Effects of recombinant interleukin-1-receptor antagonist.
Barriere
S L
SL
Pribble
J P
JP
D000818:Animals; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D051381:Rats; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012772:Shock, Septic / Q000401:mortality / Q000517:prevention & control*; D012795:Sialoglycoproteins / Q000008:administration & dosage / Q000627:therapeutic use*
C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D012795:Sialoglycoproteins